Based on the Cassava Sciences Inc stock forecast from 1 analysts, the average analyst target price for Cassava Sciences Inc is USD 107.00 over the next 12 months. Cassava Sciences Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Cassava Sciences Inc is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Cassava Sciences Inc’s stock price was USD 2.41. Cassava Sciences Inc’s stock price has changed by -9.40% over the past week, -90.90% over the past month and -89.93% over the last year.
No recent analyst target price found for Cassava Sciences Inc
No recent average analyst rating found for Cassava Sciences Inc
Company Overview Cassava Sciences Inc
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas. Read Less
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate i...Read More
Frequently Asked Questions About Cassava Sciences Inc (SAVA) Stock
Based on ratings from 1 analysts Cassava Sciences Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on SAVA's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for SAVA is USD 107.00 over the next 12 months. The maximum analyst target price is USD 107 while the minimum anlayst target price is USD 107.
Unfortunately we do not have enough data on SAVA's stock to indicate if its overvalued.
The last closing price of SAVA's stock was USD 2.41.
The most recent market capitalization for SAVA is USD 0.11B.
Based on targets from 1 analysts, the average taret price for SAVA is projected at USD 107.00 over the next 12 months.
This means that SAVA's stock price may go up by +4,339.83% over the next 12 months.
We can't find any ETFs which contains Cassava Sciences Inc's stock.
As per our most recent records Cassava Sciences Inc has 29 Employees.
Cassava Sciences Inc's registered address is 6801 N. Capital of Texas Highway, Austin, TX, United States, 78731.
You can get more information about it from Cassava Sciences Inc's website at https://www.cassavasciences.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Cassava Sciences Inc (SAVA) Stock
Based on ratings from 1 analysts Cassava Sciences Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on SAVA's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for SAVA is USD 107.00 over the next 12 months. The maximum analyst target price is USD 107 while the minimum anlayst target price is USD 107.
Unfortunately we do not have enough data on SAVA's stock to indicate if its overvalued.
The last closing price of SAVA's stock was USD 2.41.
The most recent market capitalization for SAVA is USD 0.11B.
Based on targets from 1 analysts, the average taret price for SAVA is projected at USD 107.00 over the next 12 months.
This means that SAVA's stock price may go up by +4,339.83% over the next 12 months.
We can't find any ETFs which contains Cassava Sciences Inc's stock.
As per our most recent records Cassava Sciences Inc has 29 Employees.
Cassava Sciences Inc's registered address is 6801 N. Capital of Texas Highway, Austin, TX, United States, 78731.
You can get more information about it from Cassava Sciences Inc's website at https://www.cassavasciences.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SAVA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
